Allison Imrie

Assistant Researcher

Retrovirology Research Laboratory

Atherton Building, Leahi Hospital, Second Floor

3675 Kilauea Avenue, Honolulu, Hawaii 96816

TEL (808) 732-7702

FAX (808)735-3682

email: imrie@pbrc.hawaii.edu

Education
University of Sydney, Sydney, Australia B.Sc 1982 biochemistry
microbiology
University of New South Wales, Sydney, Australia Ph.D. 1997 virology

Experience

2000- Assistant Researcher, Retrovirology Research Laboratory, Pacific Biomedical Research Center, University of Hawaii at Manoa, Honolulu, Hawaii
2000 Junior Researcher, Retrovirology Research Laboratory, Pacific Biomedical Research Center, University of Hawaii at Manoa, Honolulu, Hawaii
1996 Research Associate, Retrovirology Research Laboratory, Pacific Biomedical Research Center, University of Hawaii at Manoa, Honolulu, Hawaii
1995 Senior Scientist, Centre for Immunology, St Vincentís Hospital, Sydney, Australia
1990  Short-term consultant scientist, Global Program on AIDS, World Health Organization, Manila, Philippines
1985-1990 Scientific Officer, Centre for Immunology, St Vincentís Hospital, Sydney, Australia

Publications

  1. Imrie A, Kehrer S, Smith GW, Penny R, and Cooper DA. Seroimmunology of AIDS retrovirus infection 1. Use of immunofluorescence assay to confirm sera with ELISA reactivity. Pathology [1986] 18:438-443.
  2. Imrie A, Best S, Penny R, and Cooper DA. False negative ELISA result for HIV antibody due to an apparent prozone phenomenon. Medical Journal of Australia [1987] 147:42.
  3. Wodak A, Dolan K, Imrie AA, Gold J, Wolk J, Whyte B, and Cooper DA. Antibodies to the human immunodeficiency virus in needles and syringes used by intravenous drug abusers. Medical Journal of Australia [1987] 147:275-276.
  4. Cooper DA, Imrie A, and Penny R. Antibody response to human immunodeficiency virus after primary HIV infection. Journal of Infectious Diseases [1987] 155:1113-118.
  5. Cooper DA, Tindall B, Wilson EJ, Imrie AA, and Penny R. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. Journal of Infectious Diseases [1988] 157:889-896.
  6. Nasveld P, Slayter M, Dow R, Imrie A, and Rudzki S. A biological false-positive result for human immunodeficiency virus type-1 in an army recruit. Medical Journal of Australia [1988] 149:44.
  7. Tindall B, Cotton R, Swanson C, Perdices M, Bodsworth N, Imrie A, and Cooper DA. Fifth international conference on the acquired immunodeficiency syndrome. Medical Journal of Australia [1990] 153:383-386.
  8. McLaws, M-L, Brown ARD, Cunningham PH, Imrie AA, Wilcken B, and Cooper DA. Prevalence of maternal HIV infection based on anonymous testing of neonates, Sydney 1989. Medical Journal of Australia [1990] 153:383-386.
  9. Tindall B, Imrie A, Donovan B, Penny R, and Cooper DA. Primary HIV infection : Clinical, Immunologic and Serologic Aspects. In: The Medical management of AIDS Second Edition (1990). Merle A Sande and Paul A Volberding, editors.
  10. Tindall B, Gaines H, Imrie A, von Sydow MAE, Evans L, Strannegard O, Tsang ML, Lindback S, and Cooper DA. Zidovudine in the management of primary HIV infection. Journal of Infectious Diseases [1991] 5:477-484.
  11. Healey D, Maskill WJ, Howard TS, Armstrong VA, Bolton WV, Cooper GJ, Downie JC, Hiley LA, Imrie AA, Johnson S, Robertson PW, and Schepetiuk S. HIV-1 Western Blot: development and assessment of testing to resolve indeterminate reactivity. AIDS [1992] 6:629-633.
  12. Tindall B, Imrie A, Donovan B, Penny R, and Cooper DA. Primary HIV infection : Clinical, Immunologic and Serologic Aspects. In: The Medical management of AIDS Third Edition (1992). Merle A Sande and Paul A Volberding, editors.
  13. Kaldor J, Williamson P, Guinan JJ, Imrie A, and Gold J. Falling incidence of HIV infection in a cohort of clinic attenders. Australian Journal of Public Health [1993] 17:334-338.
  14. de Jong MD, Lowenthal M, Boucher CAB, van der Ende I, Hall D, Schipper P, Imrie A, Weigel HM, Kauffmann RH, Koster R, Seville P, Rocklin R, Cooper DA, and Lange JMA. Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type-1 infected persons does not prolong nevirapine activity. Journal of Infectius Diseases [1994] 169:1346-50.
  15. McDonald AM, Imrie A, Neilson G, Downie J, Gertig DM, Robertson P, Guinan J, Mullins S, Kaldor JM. Assessment of self-report in HIV surveillance: a pilot study. Australian Journal of Public Health [1994] 18:429-432.
  16. Imrie A, Carr A, Duncombe C, Finlayson R, Vizzard J, Kaldor J, Penny R, Cooper DA, and the Sydney Primary HIV Infection Study Group. Primary Infection with zidovudine-resistant HIV-1 does not adversely affect outcome at 1 year. Journal of Infectious Diseases [1996] 174:195-198.
  17. Carr A, Vella S, de Jong MD, Imrie A, French M, Sorice S, Pauluzzi S, Chiodi F, Boucher CAB, Reiss P, van der Ende ME, Frissen PHJ, Weigel HM, Kaufmann R, Lange JMA, Yoon R, Moroni M, Hoenderos E, Leitz G, Hall D, and Cooper DA. A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. AIDS [1996] 6:635-641.
  18. Imrie A, Genn W, Beveridge A, Vizzard J, Cooper DA, and the Sydney primary HIV Infection Study Group. Transmission of HIV-1 highly resistant to the non-nucleoside reverse transcriptase inhibitor nevirapine. Antiviral Therapy [1996] 1(S1).
  19. de Jong MD, Vella S, Carr A, Boucher CA, Imrie A, French M, Hoy J, Sourice S, Pauluzzi S, Chioda F, Weverling GJ, van der Ende ME, Frissen P-J, Weigel MM, Kauffmann RH, Lange JMA, Yoon R, Moreni M, Woenderos E, Leitz G, Cooper DA, Hall D, and Reiss P. High-dose nevirapine in previously untreated human immunodeficiency virus type-1 infected persons does not result in sustained suppression of viral replication. Journal of Infectious Diseases [1997] 175:966-970.
  20. Imrie A, Beveridge A, Genn W, Vizzard J, Cooper DA, and the Sydney Primary HIV Infection Study Group. Transmission of human immunodeficiency virus type-1 resistant to nevirapine and zidovudine. Journal of Infectious Disease [1997] 175:1502-1506.
  21. Shikuma CM, Waslien C, McKeague J, Baker N, Arakaki M, Cui XW, Souza S, Imrie A, and Arakaki R. Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS. AIDS [1999] 13:1359-1365.
  22. Vanhems P, Gaudet R, Hirschel B, Imrie A, Conway B, Rouleau D, Vizzard J, Perrin L, Cooper DA, and Yerly S. Clinical features of acute HV-1 infection: zidovudine-resistant isolates compared to zidovudine-sensitive isolates. AIDS [2000] 14:1065-1067.